Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
Clinical trial NCT00771615 · COMPLETED
Trial details
- NCT number
- NCT00771615
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-16
- Primary completion
- 2009-05-26
- Enrollment
- 469
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.